These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2054511)

  • 1. [The effect of finoptin on the metabolism and pharmacological action of cyclophosphane in vivo and in vitro].
    Donenko FV; Chikvashvili BSh; Borovkova NB; Devichenskiĭ VM; Kabieva AO; Korneva EN; Telegin LIu; Shcherbakov VM; Letiagin VP; Moroz LV
    Biull Eksp Biol Med; 1991 Mar; 111(3):300-2. PubMed ID: 2054511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible mechanism of the alteration in the therapeutic action of cyclophosphane in mice with hemocytoblastosis La against a background of artificial hyperglycemia].
    Kabieva AO; Donenko FV
    Eksp Onkol; 1988; 10(4):66-8, 71. PubMed ID: 3181078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
    Kanekal S; Kehrer JP
    Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of verapamil on the clastogenic effect of cyclophosphane in somatic cells from BALB/c and C57Bl/6 mice].
    Seredenin SB; Durnev AD; Nesterova EV
    Eksp Klin Farmakol; 1999; 62(2):51-4. PubMed ID: 10340131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
    Konovalova NP; Volkova LM; Klochko AV
    Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.
    Anderson LW; Chen TL; Colvin OM; Grochow LB; Collins JM; Kennedy MJ; Strong JM
    Clin Cancer Res; 1996 Sep; 2(9):1481-7. PubMed ID: 9816324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect.
    Donelli MG; Bartosek I; Guaitani A; Martini A; Colombo T; Pacciarini MA; Modica R
    Cancer Treat Rep; 1976 Apr; 60(4):395-401. PubMed ID: 1277213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction of the complex copper compound Cu-2 with liver monooxygenases].
    Bogush TA; Donenko FV; Sitdikova SM; Andronova NV
    Biull Eksp Biol Med; 1987 Oct; 104(10):438-40. PubMed ID: 3676462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide.
    Ding Q; Kestell P; Baguley BC; Palmer BD; Paxton JW; Muller G; Ching LM
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):186-92. PubMed ID: 12203100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
    Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
    Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of cyclophosphane in different morphological variants of glomerulonephritis in mice].
    Samoĭlov DV; Ivanov AA; Gladskikh OP; Krasnova TN; Shilov EM; Pal'tsev MA; Tareeva IE
    Arkh Patol; 1990; 52(4):53-7. PubMed ID: 2386442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.
    Al-Rawithi S; El-Yazigi A; Ernst P; Al-Fiar F; Nicholls PJ
    Bone Marrow Transplant; 1998 Sep; 22(5):485-90. PubMed ID: 9733272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of the cyclophosphane administration regimen for its immunomodulating and antitumor effect in experimental chemotherapy].
    Kovbasiuk SA
    Vopr Onkol; 1985; 31(7):91-7. PubMed ID: 4024566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.